Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Physician Dispensed Cosmeceutical market in this environment.
In terms of revenue, this research report indicated that the global Physician Dispensed Cosmeceutical market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Physician Dispensed Cosmeceutical industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Allergan aims at producing XX Physician Dispensed Cosmeceutical in 2020, with XX % production to take place in global market, ? ? Jan Marini Skin Research accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Physician Dispensed Cosmeceutical Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Physician Dispensed Cosmeceutical Market?
Allergan
Jan Marini Skin Research
Johnson & Johnson
Procter & Gamble
Valeant Pharmaceuticals
Unilever
ZO Skin Health Inc
...
Major Type of Physician Dispensed Cosmeceutical Covered in XYZResearch report:
Type I
Type II
Application Segments Covered in XYZResearch Market
Application 1
Application 2
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Physician Dispensed Cosmeceutical Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Type I -Product Introduction and Major Manufacturers
1.1.2 Type II -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Physician Dispensed Cosmeceutical Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Physician Dispensed Cosmeceutical Market
3.1.1 Top Companies leading Physician Dispensed Cosmeceutical Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Physician Dispensed Cosmeceutical Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Physician Dispensed Cosmeceutical Market
3.2.1 Top Companies leading Physician Dispensed Cosmeceutical Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Physician Dispensed Cosmeceutical Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Physician Dispensed Cosmeceutical Market
3.3.1 Top Companies leading Physician Dispensed Cosmeceutical Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Physician Dispensed Cosmeceutical Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Physician Dispensed Cosmeceutical Market
3.4.1 Top Companies leading Physician Dispensed Cosmeceutical Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Physician Dispensed Cosmeceutical Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Physician Dispensed Cosmeceutical Market
3.5.1 Top Companies leading Physician Dispensed Cosmeceutical Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Physician Dispensed Cosmeceutical Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Physician Dispensed Cosmeceutical Market
3.6.1 Top Companies leading Physician Dispensed Cosmeceutical Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Physician Dispensed Cosmeceutical Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Physician Dispensed Cosmeceutical Market
3.7.1 Top Companies leading Physician Dispensed Cosmeceutical Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Physician Dispensed Cosmeceutical Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Physician Dispensed Cosmeceutical Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Physician Dispensed Cosmeceutical Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Physician Dispensed Cosmeceutical Sales and Growth Rate (2021-2026)
5.2 Global Physician Dispensed Cosmeceutical Sales Value and Growth Rate (2021-2026)
6 Physician Dispensed Cosmeceutical Competitive Analysis
6.1 Allergan
6.1.1 Allergan Company Profiles
6.1.2 Allergan Product Introduction
6.1.3 Allergan Physician Dispensed Cosmeceutical Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 Jan Marini Skin Research
6.2.1 Jan Marini Skin Research Company Profiles
6.2.2 Jan Marini Skin Research Product Introduction
6.2.3 Jan Marini Skin Research Physician Dispensed Cosmeceutical Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Profiles
6.3.2 Johnson & Johnson Product Introduction
6.3.3 Johnson & Johnson Physician Dispensed Cosmeceutical Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Procter & Gamble
6.4.1 Procter & Gamble Company Profiles
6.4.2 Procter & Gamble Product Introduction
6.4.3 Procter & Gamble Physician Dispensed Cosmeceutical Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Valeant Pharmaceuticals
6.5.1 Valeant Pharmaceuticals Company Profiles
6.5.2 Valeant Pharmaceuticals Product Introduction
6.5.3 Valeant Pharmaceuticals Physician Dispensed Cosmeceutical Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Unilever
6.6.1 Unilever Company Profiles
6.6.2 Unilever Product Introduction
6.6.3 Unilever Physician Dispensed Cosmeceutical Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 ZO Skin Health Inc
6.7.1 ZO Skin Health Inc Company Profiles
6.7.2 ZO Skin Health Inc Product Introduction
6.7.3 ZO Skin Health Inc Physician Dispensed Cosmeceutical Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
7 Conclusion
The Specialty Physician Staffing Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
The Physician and Nurse Recruitment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Physician Advisory Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Mobile Physician Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Medicare Physician Payment Schedule Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Home-Based Physician Care Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Physician Dispensing Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
Overview of the Global Healthcare Physician Recruitment Management Market:
The report discusses everything a marketer requires before investing in the global Healthcare Physician Recruitment Management Market during...
Overview of the Global P2P Healthcare Physician Staffing Market:
The report discusses everything a marketer requires before investing in the global P2P Healthcare Physician Staffing Market during the forecast period...
Overview of the Global Cloud-based Healthcare Physician Staffing Market:
The report discusses everything a marketer requires before investing in the global Cloud-based Healthcare Physician Staffing Market during the...